← Leaderboards
Guillermo Garcia-Cardena
Brigham And Women'S Hospital
$4,874,766
Attributed
$7,798,245
Total exposure
7
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$7,798,245 · 7
By mechanism
R01$3,280,422 · 2
R44$2,804,643 · 1
R21$1,171,748 · 3
R41$541,432 · 1
Top collaborators
- William James Adams7 shared
- Terrie Ellen Taylor4 shared
- Jeffrey T Borenstein3 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- John P Forman$11,830,902
- Elizabeth W Karlson$93,612,751
- Y. Shrike Zhang$13,550,158
- William James Adams$2,113,532
- Michael A Gimbrone$16,320,214
Others in their field
Top investigators on “Blood Vessels”
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Charles Decarli · University Of California At Davis$66,498,201
- Josef Coresh · New York University School Of Medicine$63,693,760
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$62,000,770
- Robert P Kimberly · University Of Alabama At Birmingham$56,093,149
Research focus
Blood VesselsPhenotypeBaseBiologicalHemodynamicsResponseCellsProgramsInsightLeadEnvironmentCardiovascular DiseasesMorbidity - Disease RateLaboratoriesEndothelial CellsSignal TransductionSignal PathwayPublic Health RelevanceTranslatingCell PhysiologyFunctional DisorderShear StressEndothelial DysfunctionBiomechanics
Grant awards (21)
Flow-dependent endothelial cell signaling$223,750
R21 · FY2021 · HL · contact PI
Flow-dependent endothelial cell signaling$268,500
R21 · FY2020 · HL · contact PI
Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis$697,873
R44 · FY2018 · HL
Vascular Dysfunction in the Pathogenesis of Severe Malaria$443,422
R01 · FY2018 · HL
Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis$1,229,878
R44 · FY2017 · HL
Vascular Dysfunction in the Pathogenesis of Severe Malaria$447,423
R01 · FY2017 · HL
Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis$19,598
R44 · FY2017 · HL
Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis$857,294
R44 · FY2016 · HL
Vascular Dysfunction in the Pathogenesis of Severe Malaria$450,395
R01 · FY2016 · HL
Vascular Dysfunction in the Pathogenesis of Severe Malaria$480,145
R01 · FY2015 · HL
Pharmacological Targeting of Endothelial Dysfunction in Atherogenesis$292,909
R41 · FY2014 · HL
Pharmacological Targeting of Endothelial Dysfunction in Atherogenesis$3,398
R41 · FY2014 · HL
Pharmacological Targeting of Endothelial Dysfunction in Atherogenesis$245,125
R41 · FY2013 · HL
A High-Throughput Flow System to Probe Biomechanics of Pathophysiology$243,672
R21 · FY2012 · GM
A High-Throughput Flow System to Probe Biomechanics of Pathophysiology$216,818
R21 · FY2011 · RR
A High-Throughput Flow System to Probe Biomechanics of Pathophysiology$219,008
R21 · FY2010 · RR
CONTROL OF ENDOTHELIAL IDENTITY BY HEMODYNAMIC FORCES$282,840
R01 · FY2008 · HL · contact PI
CONTROL OF ENDOTHELIAL IDENTITY BY HEMODYNAMIC FORCES$282,840
R01 · FY2007 · HL · contact PI
CONTROL OF ENDOTHELIAL IDENTITY BY HEMODYNAMIC FORCES$291,288
R01 · FY2006 · HL · contact PI
CONTROL OF ENDOTHELIAL IDENTITY BY HEMODYNAMIC FORCES$299,319
R01 · FY2005 · HL
CONTROL OF ENDOTHELIAL IDENTITY BY HEMODYNAMIC FORCES$302,750
R01 · FY2004 · HL